The inflammation-mediated role of the HMGB1/TLR4/NF-κB signaling pathway in diseases such as asthma, rheumatoid arthritis, lung injury, sepsis, and SLE and its associated complications (such as LN) has received widespread attention. Here, HMGB1 is linked to systemic lupus erythematosus.